M. Nakayama

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy

Yusuke Suzuki, Hitoshi Suzuki, K. Jeong, 2022, Journal of clinical medicine.

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy

Yusuke Suzuki, Hitoshi Suzuki, Y. Fukao, 2020, CEN Case Reports.

Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases

Yusuke Suzuki, Hitoshi Suzuki, Yu Sasaki, 2020, BMC Nephrology.

The leukotriene B4/BLT1‐dependent neutrophil accumulation exacerbates immune complex‐mediated glomerulonephritis

Yusuke Suzuki, T. Yokomizo, Kazuko Saeki, 2023, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy

Yusuke Suzuki, Hitoshi Suzuki, M. Muto, 2022, Biomedicines.

Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy

Yusuke Suzuki, S. Kazuno, D. Kitamura, 2023, Science advances.

The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy.

Yusuke Suzuki, M. Muto, Y. Fukao, 2023, Kidney international.